The company omitted information about the administrative process in the National Institute of Industrial Property (INPI in its acronym in Portuguese), and a series of relevant information about the change of scope in the patent request.
by assint
published
em
Jun 25, 2015
—
last modified
em
Apr 08, 2016 10:40 AM
filed under:
condemnation,
tribunal,
eli lilly,
sham litigation,
administratif proceeding,
medicines,
distrito federal,
rio de janeiro,
São Paulo
